关注
PROF. BIKASH MEDHI
PROF. BIKASH MEDHI
Department of Pharmacology, PGIMER
在 pgimer.edu.in 的电子邮件经过验证 - 首页
标题
引用次数
引用次数
年份
Drug targets for corona virus: A systematic review
M Prajapat, P Sarma, N Shekhar, P Avti, S Sinha, H Kaur, S Kumar, ...
Indian journal of pharmacology 52 (1), 56-65, 2020
5522020
Bacteria in cancer therapy: a novel experimental strategy
S Patyar, R Joshi, DSP Byrav, A Prakash, B Medhi, BK Das
Journal of biomedical science 17, 1-9, 2010
3812010
Honey--a remedy rediscovered and its therapeutic utility.
V Bansal, B Medhi, P Pandhi
Kathmandu University medical journal (KUMJ) 3 (3), 305-309, 2005
2482005
Virological and clinical cure in COVID‐19 patients treated with hydroxychloroquine: a systematic review and meta‐analysis
P Sarma, H Kaur, H Kumar, D Mahendru, P Avti, A Bhattacharyya, ...
Journal of medical virology 92 (7), 776-785, 2020
2352020
In-silico homology assisted identification of inhibitor of RNA binding against 2019-nCoV N-protein (N terminal domain)
P Sarma, N Shekhar, M Prajapat, P Avti, H Kaur, S Kumar, S Singh, ...
Journal of Biomolecular Structure and Dynamics 39 (8), 2724-2732, 2021
2252021
Challenges of drug-resistant malaria
S Sinha, B Medhi, R Sehgal
Parasite 21, 2014
1742014
Serum ferritin as a predictive biomarker in COVID-19. A systematic review, meta-analysis and meta-regression analysis
K Kaushal, H Kaur, P Sarma, A Bhattacharyya, DJ Sharma, M Prajapat, ...
Journal of critical care 67, 172-181, 2022
1622022
Role of vinpocetine in cerebrovascular diseases
S Patyar, A Prakash, M Modi, B Medhi
Pharmacological Reports 63 (3), 618-628, 2011
1612011
Recent advances in molecular pathways and therapeutic implications targeting neuroinflammation for Alzheimer’s disease
R Dhapola, SS Hota, P Sarma, A Bhattacharyya, B Medhi, DHK Reddy
Inflammopharmacology, 1-13, 2021
1512021
Pharmacokinetic and toxicological profile of artemisinin compounds: an update
B Medhi, S Patyar, RS Rao, P Byrav DS, A Prakash
Pharmacology 84 (6), 323-332, 2009
1212009
Ivermectin as a potential drug for treatment of COVID-19: an in-sync review with clinical and computational attributes
H Kaur, N Shekhar, S Sharma, P Sarma, A Prakash, B Medhi
Pharmacological Reports 73, 736-749, 2021
1182021
Drug therapy in stroke: from preclinical to clinical studies
H Kaur, A Prakash, B Medhi
Pharmacology 92 (5-6), 324-334, 2014
1142014
Galantamine-loaded solid–lipid nanoparticles for enhanced brain delivery: preparation, characterization, in vitro and in vivo evaluations
S Misra, K Chopra, VR Sinha, B Medhi
Drug delivery 23 (4), 1434-1443, 2016
1132016
Neuroinflammation in Alzheimer’s disease: current progress in molecular signaling and therapeutics
S Thakur, R Dhapola, P Sarma, B Medhi, DHK Reddy
Inflammation 46 (1), 1-17, 2023
1092023
Drug therapy in autism: a present and future perspective
B Kumar, A Prakash, RK Sewal, B Medhi, M Modi
Pharmacological Reports 64 (6), 1291-1304, 2012
1092012
Nanomedicine in central nervous system (CNS) disorders: a present and future prospective
S Soni, RK Ruhela, B Medhi
Advanced pharmaceutical bulletin 6 (3), 319, 2016
1032016
Topical application of honey in the treatment of wound healing: a metaanalysis
B Medhi, A Puri, S Upadhyay, L Kaman
JK Sci 10 (4), 166-169, 2008
1032008
Therapeutic options for the treatment of 2019‑novel coronavirus: An evidence‑based approach
BM Phulen Sarma, Manisha Prajapat, Pramod Avti1, Hardeep Kaur, Subodh Kumar
Indian J Pharmacol 52 (1), 1-5, 2020
1012020
COVID-19 pandemic: A review based on current evidence
VM Mahalmani, D Mahendru, A Semwal, S Kaur, H Kaur, P Sarma, ...
Indian journal of pharmacology 52 (2), 117-129, 2020
892020
Effect of different doses of Manuka honey in experimentally induced inflammatory bowel disease in rats
A Prakash, B Medhi, PK Avti, UN Saikia, P Pandhi, KL Khanduja
Phytotherapy Research: An International Journal Devoted to Pharmacological …, 2008
882008
系统目前无法执行此操作,请稍后再试。
文章 1–20